LK101 Research and Lecheng Access: Questions for the Hospital
For an LK101 enquiry in Hainan, China, first ask the hospital which pathway applies and whether it can assess your case. Manufacturer materials, clinical-trial records and an appointment are different things. This guide, checked on 10 October 2026, separates those sources so you can ask about current access without treating research clearance as general marketing approval.
What the manufacturer materials say
Likang’s brochure reports LK101 investigational clearances from China’s NMPA and the U.S. FDA, plus a translational-application pathway in Hainan Boao Lecheng, China. These are manufacturer statements. They do not establish general drug marketing authorization. The FDA’s IND guidance states: “The IND is not an application for marketing approval.”
Read registry status with its dates
On the 10 October 2026 check, ClinicalTrials.gov record NCT06054932 showed UNKNOWN status, last known RECRUITING, with the last update posted on 26 September 2023. Record NCT05886439 showed RECRUITING, with the last update posted on 8 December 2025. These are registry snapshots; neither confirms that an individual can enrol or obtain treatment now.
Questions for the hospital before travel
The supplied technical manual names Sichuan University West China Lecheng Hospital. The hospital’s own website lists its address in Qionghai, Hainan, China. A named hospital is a starting point for an enquiry, not confirmation of a current LK101 appointment.
- Which research or local access pathway would apply to this enquiry?
- Is the relevant programme currently accepting assessments, and who decides eligibility?
- What records are needed, and when can the hospital confirm the appointment arrangements?
Uwell’s role and the sources
Uwell helps coordinate enquiries and medical-record preparation. Eligibility and treatment decisions remain with the clinical team. Medical fees are quoted and collected directly by the provider; Uwell does not collect medical fees.
Source documents and dated records: Likang brochure; Likang technical manual; NCT06054932; NCT05886439.
Frequently asked questions
Does an IND mean the drug is approved for marketing?
Does RECRUITING mean I can book treatment?
Who confirms the medical plan and costs?
This article was produced with AI assistance and reviewed against Uwell Cloud editorial and compliance standards.